The legal war between pharmaceutical firm Wockhardt and Singapore based DBS Bank came to an end as both parties have reached an out-of-court settlement to solve the corporate debt restructuring (CDR) case.

A consent decree in the Bombay High Court has been filed in the court on Monday as Wockhardt gave its nod to settle MTM losses at Rs 91 crore. The repayment of an Rs 44 crore working capital loan taken in 2007 has been settled at a 19 per cent discount according to a person familiar with the development.

DBS moved in Bombay High Court last month urging it to liquidate Wockhardt for failing to meet its obligations. Calyon and Barclays Bank have also filed similar winding-up petition seeking court’s intervention to resolve the disputes.

Wockhardt, having Rs 44 crore working cap loans with DBS, is learnt to have solved the working capital loans with DBS by paying Rs 37 crore as settlement. The troubled Indian drug maker, however, declined to divulge more details. DBS officials could not be contacted despite repeated attempts.